Airway Management Devices Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Airway management devices are critical medical instruments designed to prevent airway obstruction, facilitate ventilation, and ensure adequate oxygenation during surgical procedures, emergency resuscitation, and intensive care. The global market stood at approximately $2.745 billion in 2026 and is on a trajectory to reach roughly $4.35 billion by 2033, representing a compound annual growth rate of 6.8%. Product categories include supraglottic devices, infraglottic devices, and resuscitators, with single-use products now commanding the majority share due to infection control priorities.

• •Market valued at approximately $2.74 billion in 2026, with projected growth to $4.35 billion by 2033 at a 6.8% CAGR
• •Single-use devices dominate at 62.0% market share, reflecting widespread preference for disposable solutions
• •Supraglottic airway devices lead the product-type segment with a 36.6% share, driven by continuous safety and convenience innovations

The market is propelled by the escalating global burden of respiratory disease, with an estimated 545 million individuals currently living with chronic respiratory conditions according to data from the National Institutes of Health. An aging worldwide population is increasing the prevalence of comorbidities requiring airway management during surgery, intensive care, and emergency interventions. Concurrently, ongoing improvements in medical device technology, such as enhanced ergonomics, materials, and integrated monitoring features, are expanding the range of clinical applications and adoption rates.

• •Approximately 545 million people globally live with chronic respiratory conditions (7.4% of world population), fueling sustained demand
• •Rising volume of surgical procedures, trauma cases, and intensive care admissions requiring airway intervention
• •Technological advancements in device design, materials, and patient safety features broadening adoption across care settings

The market is segmented primarily by product type, supraglottic, infraglottic, and resuscitators, with supraglottic devices leading at 36.6% share in 2026 due to their balance of efficacy and ease of use. By patient type, the adult segment dominates at 81.6%, driven by the expanding elderly population and higher incidence of adult respiratory illnesses. Usage-based segmentation reveals single-use devices at 62.0% share, as healthcare facilities increasingly favor disposable options to minimize cross-contamination risks and associated costs.

• •Supraglottic devices hold 36.6% share by device type; adult patients represent 81.6% of the market
• •Single-use segment leads at 62.0% market share, driven by infection control and cost-efficiency preferences
• •North America commands the largest regional share at 39.7%, supported by well-developed healthcare infrastructure and high procedural volumes

Who are the notable companies in the industry?

The competitive structure of the airway management devices market is moderately fragmented, shaped by a combination of large, diversified medical device manufacturers and smaller specialty producers focused on particular product categories. Leading participants include **Medtronic**, **Smiths Medical**, and **Teleflex Incorporated** in the United States, which operate across the full value chain from materials sourcing through finished airway management equipment such as endotracheal tubes, laryngoscope handles and blades, positive airway pressure devices, and oropharyngeal airways. **Ambu A/S** of Denmark is similarly positioned as a broad-portfolio player in the field. Alongside these, regionally anchored specialists including **Intersurgical Ltd.** and **Flexicare Medical Limited** in the United Kingdom, together with **Vyaire Medical Inc.** and **Medline Industries, Inc.** in the United States, focus on specific airway and respiratory device categories, often relying on external partners for manufacturing or distribution. Integration therefore varies considerably across competitors, as does investment in R&D aimed at developing technologically advanced respiratory devices for use in operating rooms, emergency departments, and ICUs. Manufacturing capacity remains concentrated in North America and Europe, though production footprints are gradually expanding into Asia-Pacific as companies pursue supply-chain diversification.

• •Moderately fragmented market with a mix of integrated diversified manufacturers and specialized single-category producers
• •Primary manufacturing processes include precision molding and assembly of medical-grade polymers, silicone, and elastomers
• •Production capacity concentrated in North America and Western Europe, with incremental expansion in Asia-Pacific

What are the recent trends and outlook?

Looking ahead, the market is expected to sustain its 6.8% CAGR through 2033, reaching approximately $4.35 billion, as demand continues to be undergirded by persistent respiratory disease prevalence, aging demographics, and expanding surgical and emergency care volumes. Key trends include accelerating the shift toward single-use and antimicrobial-infused devices, the incorporation of digital connectivity and real-time monitoring into airway equipment, and growing adoption in emerging markets as healthcare infrastructure improves. These factors collectively point to sustained long-term expansion, with innovation in safety, usability, and infection prevention remaining central to competitive positioning across the industry.

• •Projected to reach $4.35 billion by 2033 at a 6.8% CAGR, driven by persistent disease burden and aging demographics
• •Rising preference for single-use, antimicrobial, and digitally integrated airway management solutions
• •Emerging market healthcare infrastructure expansion creating new demand pools beyond established regions